Fumaric Acid

Fumaric Acid

SCHEMBL7866342

CC(C)N1CC=C(c2cc3ccc([N+](=O)[O-])cc3[nH]2)CC1.O=C(O)C=CC(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 1/20 0.39
MEN1 known ✓ O00255 2/20 0.34
KMT2A known ✓ Q03164 2/20 0.34
KCNH2 known ✓ Q12809 1/20 0.34
HRH3 known ✓ Q9Y5N1 1/20 0.34
HRH4 Q9H3N8 2/20 0.42
VCP P55072 2/20 0.41
ALDH1A1 P00352 5/20 0.40
LMNA P02545 2/20 0.40
PMP22 Q01453 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP19A1 P11511 2/20 0.37
BAZ2B Q9UIF8 1/20 0.37
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALOX15 P16050 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
CCNT1 O60563 1/20 0.34
CDK9 P50750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL7866335 1.00 HRH4 (0.42) HRH4VCPALDH1A1LMNAPMP22
Fumaric Acid SCHEMBL7866340 1.00 HRH4 (0.42) HRH4VCPALDH1A1LMNAPMP22
Fumaric Acid SCHEMBL7865133 0.93 CYP19A1 (0.45) HRH4VCPALDH1A1LMNAPMP22
Fumaric Acid SCHEMBL7865131 0.93 CYP19A1 (0.45) HRH4VCPALDH1A1LMNAPMP22
Maleic Acid SCHEMBL7865126 0.93 CYP19A1 (0.45) HRH4VCPALDH1A1LMNAPMP22
Maleic Acid SCHEMBL7867976 0.81 SLC6A4 (0.55) LMNASLC6A4KDM4ENPC1ALOX15
Fumaric Acid SCHEMBL7870869 0.81 ALDH1A1 (0.38) ALDH1A1LMNAPMP22NPSR1SLC6A4
Fumaric Acid SCHEMBL7867985 0.81 SLC6A4 (0.55) LMNASLC6A4KDM4ENPC1ALOX15
Maleic Acid SCHEMBL7870864 0.81 ALDH1A1 (0.38) ALDH1A1LMNAPMP22NPSR1SLC6A4
Fumaric Acid SCHEMBL7867375 0.81 HRH4 (0.44) HRH4ALDH1A1LMNAKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077213-A2 Inhibition of serotonin reuptake ELI LILLY AND COMPANY (US) 2001-02-21 EP disclosed
US-6046215-A A PIPERIDINYLBENZOTHIOPHENES USEFUL FOR TRATING BRAIN DISORDERS ELI LILLY AND COMPANY (US) 2000-04-04 US disclosed
US-5846982-A Inhibition of serotonin reuptake ELI LILLY AND COMPANY (US) 1998-12-08 US disclosed
WO-1997047302-A1 INHIBITION OF SEROTONIN REUPTAKE ELI LILLY AND COMPANY (US) 1997-12-18 WO disclosed
EP-0812826-A1 1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake ELI LILLY AND COMPANY (US) 1997-12-17 EP disclosed